Bexion Pharmaceuticals announces the opening of study using BXQ-350 in treatment of rare tumors
Covington-based Bexion Pharmaceuticals, Inc., a clinical stage oncology company, has announced the initiation of an open-label Phase 1 Safety Study…
Ellen Flannery
Read More